ARDX ARDELYX, INC.
Nasdaq · SEC CIK 1437402 · EDGAR
- Bought, last 12 months
- $1.95M 1 purchases by 1 insiders
- Sold, last 12 months
- $4.30M 38 sales by 9 insiders
- Filings on record
- 324 since 2021-08-05, latest 2026-08-25 19:19
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| RAAB MICHAEL | Pres, CEO, Dir | — | $2.57M |
| MOTT DAVID M | Dir | $1.95M | — |
| Williams Laura A | See Remarks | — | $1.01M |
| Foster Eric Duane | Chief Commercial Off | — | $176.4K |
| Kelliher Mike | See Remarks | — | $162.3K |
| Reilly Joseph James | See Remarks | — | $129.3K |
| Bishop John E | See Remarks | — | $109.2K |
| Brady James Parker | CHRO | — | $84.8K |
| GRAMMER ELIZABETH A | See Remarks | — | $33.2K |
| Hohenleitner Susan | CFO | — | $27.0K |
Transactions 368
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-26 | 2025-02-24 | ARDX | MOTT DAVID M | Dir | P - Purchase | $5.00 | +77.7K | 2.02M | +4% | +$388.6K | |
| 2025-02-21 | 2025-02-20 | ARDX | Williams Laura A | Chief Medical Off | S - Sale | $5.62 | -4,941 | 303.8K | -2% | -$27.8K | |
| 2025-02-21 | 2025-02-20 | ARDX | GRAMMER ELIZABETH A | See Remarks | S - Sale | $5.62 | -4,291 | 181.0K | -2% | -$24.1K | |
| 2025-02-21 | 2025-02-20 | ARDX | Renz Justin A | CFO | S - Sale | $5.62 | -5,171 | 286.0K | -2% | -$29.1K | |
| 2025-02-21 | 2025-02-20 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | S - Sale | $5.62 | -23.0K | 1.09M | -2% | -$129.1K | |
| D | 2025-01-31 | 2025-01-31 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | S - Sale+OE | $5.36 | -41.7K | 1.11M | -4% | -$223.3K |
| D | 2025-01-31 | 2025-01-31 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | M - OptEx | $0.99 | +20.8K | 1.15M | +2% | +$20.6K |
| 2025-01-22 | 2025-01-21 | ARDX | MOTT DAVID M | Dir | P - Purchase | $4.99 | +199.0K | 1.94M | +11% | +$993.0K | |
| D | 2025-01-17 | 2025-01-16 | ARDX | Rodgers Richard J | Dir | M - OptEx | $0.55 | +100.0K | 350.5K | +40% | +$55.0K |
| D | 2025-01-10 | 2025-01-07 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | S - Sale+OE | $5.31 | -41.7K | 1.13M | -4% | -$221.2K |
| D | 2025-01-10 | 2025-01-07 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | M - OptEx | $0.99 | +20.8K | 1.17M | +2% | +$20.6K |
| D | 2024-12-27 | 2024-12-26 | ARDX | MOTT DAVID M | Dir | M - OptEx | $0.55 | +100.0K | 1.74M | +6% | +$55.0K |
| 2024-12-23 | 2024-12-19 | ARDX | MOTT DAVID M | Dir | P - Purchase | $4.67 | +213.3K | 1.64M | +15% | +$996.1K | |
| D | 2024-12-12 | 2024-12-10 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | S - Sale+OE | $5.26 | -25.0K | 1.15M | -2% | -$131.5K |
| D | 2024-12-12 | 2024-12-10 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | M - OptEx | $0.99 | +25.0K | 1.18M | +2% | +$24.8K |
| 2024-11-27 | 2024-11-25 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | S - Sale | $5.38 | -25.0K | 1.15M | -2% | -$134.5K | |
| 2024-11-22 | 2024-11-20 | ARDX | Williams Laura A | Chief Medical Off | S - Sale | $4.79 | -7,366 | 308.7K | -2% | -$35.3K | |
| 2024-11-22 | 2024-11-20 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | S - Sale | $4.79 | -32.0K | 1.18M | -3% | -$153.2K | |
| 2024-11-22 | 2024-11-20 | ARDX | Rosenbaum David P. | Chief Development Off | S - Sale | $4.79 | -4,941 | 297.0K | -2% | -$23.7K | |
| I | 2024-11-22 | 2024-11-20 | ARDX | Rosenbaum David P. | Chief Development Off | S - Sale | $4.79 | -2,243 | 151.4K | -1% | -$10.7K |
| 2024-11-22 | 2024-11-20 | ARDX | GRAMMER ELIZABETH A | See Remarks | S - Sale | $4.79 | -7,046 | 185.3K | -4% | -$33.8K | |
| 2024-11-22 | 2024-11-20 | ARDX | Renz Justin A | CFO | S - Sale | $4.79 | -5,260 | 291.1K | -2% | -$25.2K | |
| 2024-11-22 | 2024-11-20 | ARDX | Blanks Robert | See Remarks | S - Sale | $4.79 | -4,941 | 314.4K | -2% | -$23.7K | |
| 2024-11-14 | 2024-11-13 | ARDX | MOTT DAVID M | Dir | P - Purchase | $4.62 | +215.9K | 1.43M | +18% | +$997.3K | |
| 2024-11-12 | 2024-11-11 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | S - Sale | $4.90 | -2,743 | 1.21M | -0.2% | -$13.4K | |
| DI | 2024-11-08 | 2024-11-06 | ARDX | Rosenbaum David P. | Chief Development Off | M - OptEx | $2.32 | +27.2K | 180.8K | +18% | +$63.0K |
| DI | 2024-11-08 | 2024-11-06 | ARDX | Rosenbaum David P. | Chief Development Off | S - Sale+OE | $6.10 | -27.2K | 153.6K | -15% | -$165.7K |
| DI | 2024-11-06 | 2024-11-04 | ARDX | Rosenbaum David P. | Chief Development Off | S - Sale+OE | $5.95 | -27.2K | 153.6K | -15% | -$161.7K |
| DI | 2024-11-06 | 2024-11-04 | ARDX | Rosenbaum David P. | Chief Development Off | M - OptEx | $2.32 | +27.2K | 180.8K | +18% | +$63.0K |
| D | 2024-10-31 | 2024-10-28 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | M - OptEx | $0.99 | +25.0K | 1.24M | +2% | +$24.8K |
| D | 2024-10-31 | 2024-10-28 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | S - Sale+OE | $5.91 | -25.0K | 1.21M | -2% | -$147.8K |
| 2024-10-15 | 2024-10-11 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | S - Sale | $6.01 | -7,500 | 1.21M | -0.6% | -$45.1K | |
| 2024-10-01 | 2024-09-27 | ARDX | Rosenbaum David P. | Chief Development Off | S - Sale | $6.92 | -49.6K | 301.9K | -14% | -$343.0K | |
| 2024-09-27 | 2024-09-26 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | S - Sale | $6.07 | -3,000 | 1.22M | -0.2% | -$18.2K | |
| I | 2024-09-16 | 2024-09-13 | ARDX | Rosenbaum David P. | Chief Development Off | S - Sale | $6.26 | -5,312 | 153.6K | -3% | -$33.3K |
| D | 2024-09-13 | 2024-09-11 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | M - OptEx | $0.99 | +35.0K | 1.26M | +3% | +$34.6K |
| D | 2024-09-13 | 2024-09-11 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | S - Sale+OE | $5.61 | -35.0K | 1.22M | -3% | -$196.3K |
| 2024-08-28 | 2024-08-27 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | S - Sale | $6.22 | -7,500 | 1.22M | -0.6% | -$46.6K | |
| 2024-08-22 | 2024-08-20 | ARDX | Felsch Robert Ora | See Remarks | S - Sale | $5.86 | -3,567 | 91.6K | -4% | -$20.9K | |
| 2024-08-22 | 2024-08-20 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | S - Sale | $5.86 | -32.2K | 1.23M | -3% | -$188.8K | |
| 2024-08-22 | 2024-08-20 | ARDX | Rosenbaum David P. | Chief Development Off | S - Sale | $5.86 | -4,969 | 351.5K | -1% | -$29.1K | |
| I | 2024-08-22 | 2024-08-20 | ARDX | Rosenbaum David P. | Chief Development Off | S - Sale | $5.86 | -2,250 | 156.3K | -1% | -$13.2K |
| 2024-08-22 | 2024-08-20 | ARDX | Williams Laura A | Chief Medical Off | S - Sale | $5.86 | -7,412 | 314.7K | -2% | -$43.4K | |
| 2024-08-22 | 2024-08-20 | ARDX | GRAMMER ELIZABETH A | See Remarks | S - Sale | $5.86 | -7,089 | 192.4K | -4% | -$41.5K | |
| 2024-08-22 | 2024-08-20 | ARDX | Renz Justin A | CFO | S - Sale | $5.86 | -5,289 | 295.3K | -2% | -$31.0K | |
| 2024-08-22 | 2024-08-20 | ARDX | Blanks Robert | See Remarks | S - Sale | $5.86 | -4,969 | 319.4K | -2% | -$29.1K | |
| DI | 2024-08-20 | 2024-08-20 | ARDX | Rosenbaum David P. | Chief Development Off | S - Sale+OE | $6.00 | -20.5K | 158.5K | -11% | -$123.0K |
| D | 2024-08-20 | 2024-08-16 | ARDX | Rosenbaum David P. | Chief Development Off | S - Sale+OE | $5.94 | -20.0K | 356.5K | -5% | -$118.8K |
| DI | 2024-08-20 | 2024-08-20 | ARDX | Rosenbaum David P. | Chief Development Off | M - OptEx | $0.99 | +20.5K | 179.0K | +13% | +$20.3K |
| D | 2024-08-16 | 2024-08-08 | ARDX | Foster Eric Duane | Chief Commercial Off | A - Grant | $0.00 | +180.0K | 180.0K | New | $0 |
| 2024-08-14 | 2024-08-12 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | S - Sale | $5.71 | -1,229 | 1.26M | -0.1% | -$7,018 | |
| D | 2024-07-31 | 2024-07-29 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | S - Sale+OE | $5.64 | -30.0K | 1.26M | -2% | -$169.2K |
| D | 2024-07-31 | 2024-07-29 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | M - OptEx | $0.99 | +30.0K | 1.29M | +2% | +$29.7K |
| 2024-07-17 | 2024-07-15 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | S - Sale | $5.97 | -7,500 | 1.26M | -0.6% | -$44.8K | |
| 2024-06-28 | 2024-06-28 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | S - Sale | $6.59 | -2,310 | 1.27M | -0.2% | -$15.2K | |
| 2024-06-25 | 2024-06-21 | ARDX | Blanks Robert | See Remarks | S - Sale | $5.96 | -38.0K | 324.3K | -10% | -$226.5K | |
| D | 2024-06-17 | 2024-06-14 | ARDX | MOTT DAVID M | Dir | A - Grant | $0.00 | +17.3K | 1.21M | +1% | $0 |
| D | 2024-06-17 | 2024-06-13 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | S - Sale+OE | $6.65 | -35.0K | 1.27M | -3% | -$232.8K |
| D | 2024-06-17 | 2024-06-13 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | M - OptEx | $0.99 | +35.0K | 1.31M | +3% | +$34.6K |
| D | 2024-06-17 | 2024-06-14 | ARDX | Bertrand William C JR | Dir | A - Grant | $0.00 | +11.0K | 229.8K | +5% | $0 |
| D | 2024-06-17 | 2024-06-14 | ARDX | Rodgers Richard J | Dir | A - Grant | $0.00 | +12.2K | 250.5K | +5% | $0 |
| D | 2024-06-07 | 2024-06-05 | ARDX | Williams Laura A | Chief Medical Off | M - OptEx | $2.75 | +100.0K | 467.2K | +27% | +$275.0K |
| DM | 2024-06-07 | 2024-06-05 | ARDX | Williams Laura A | Chief Medical Off | S - Sale+OE | $7.13 | -145.0K | 422.2K | -26% | -$1.03M |
| I | 2024-06-05 | 2024-06-03 | ARDX | Rosenbaum David P. | Chief Development Off | S - Sale | $7.00 | -17.9K | 158.5K | -10% | -$125.1K |
| 2024-05-31 | 2024-05-29 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | S - Sale | $6.72 | -7,500 | 1.27M | -0.6% | -$50.4K | |
| 2024-05-23 | 2024-05-21 | ARDX | Renz Justin A | CFO | S - Sale | $7.81 | -5,167 | 300.5K | -2% | -$40.4K | |
| 2024-05-23 | 2024-05-21 | ARDX | Felsch Robert Ora | See Remarks | S - Sale | $7.81 | -3,485 | 95.1K | -4% | -$27.2K | |
| 2024-05-23 | 2024-05-21 | ARDX | Rosenbaum David P. | Chief Development Off | S - Sale | $7.81 | -4,855 | 376.5K | -1% | -$37.9K | |
| I | 2024-05-23 | 2024-05-21 | ARDX | Rosenbaum David P. | Chief Development Off | S - Sale | $7.81 | -2,198 | 176.4K | -1% | -$17.2K |
| 2024-05-23 | 2024-05-21 | ARDX | Blanks Robert | See Remarks | S - Sale | $7.81 | -4,855 | 362.3K | -1% | -$37.9K | |
| 2024-05-23 | 2024-05-21 | ARDX | GRAMMER ELIZABETH A | See Remarks | S - Sale | $7.81 | -6,927 | 199.5K | -3% | -$54.1K | |
| 2024-05-23 | 2024-05-21 | ARDX | Williams Laura A | Chief Medical Off | S - Sale | $7.81 | -4,794 | 367.2K | -1% | -$37.4K | |
| 2024-05-23 | 2024-05-21 | ARDX | Rodriguez Susan | Chief Commercial Off | S - Sale | $7.81 | -6,703 | 449.1K | -1% | -$52.4K | |
| 2024-05-23 | 2024-05-21 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | S - Sale | $7.81 | -31.5K | 1.28M | -2% | -$245.9K | |
| T | 2024-05-15 | 2024-05-14 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | S - Sale | $7.99 | -3,000 | 1.31M | -0.2% | -$24.0K |
| DM | 2024-05-09 | 2024-05-06 | ARDX | GRAMMER ELIZABETH A | See Remarks | S - Sale+OE | $8.88 | -284.2K | 423.7K | -40% | -$2.52M |
| DM | 2024-05-09 | 2024-05-06 | ARDX | GRAMMER ELIZABETH A | See Remarks | M - OptEx | $1.87 | +219.9K | 487.9K | +82% | +$410.8K |
| DM | 2024-05-09 | 2024-05-06 | ARDX | Felsch Robert Ora | See Remarks | S - Sale+OE | $8.81 | -208.0K | 150.9K | -58% | -$1.83M |
| DM | 2024-05-09 | 2024-05-06 | ARDX | Felsch Robert Ora | See Remarks | M - OptEx | $1.48 | +119.1K | 303.9K | +64% | +$176.4K |
| T | 2024-05-07 | 2024-05-03 | ARDX | GRAMMER ELIZABETH A | See Remarks | S - Sale | $9.00 | -45.0K | 268.0K | -14% | -$405.0K |
| DT | 2024-05-07 | 2024-05-03 | ARDX | Williams Laura A | Chief Medical Off | M - OptEx | $0.99 | +30.0K | 410.1K | +8% | +$29.7K |
| DT | 2024-05-07 | 2024-05-03 | ARDX | Williams Laura A | Chief Medical Off | S - Sale+OE | $8.35 | -39.9K | 370.2K | -10% | -$333.6K |
| DT | 2024-05-01 | 2024-04-29 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | S - Sale+OE | $6.40 | -30.0K | 1.31M | -2% | -$192.0K |
| DT | 2024-05-01 | 2024-04-29 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | M - OptEx | $0.99 | +30.0K | 1.34M | +2% | +$29.7K |
| T | 2024-04-17 | 2024-04-15 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | S - Sale | $7.06 | -7,500 | 1.31M | -0.6% | -$53.0K |
| T | 2024-04-02 | 2024-04-01 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | S - Sale | $7.31 | -1,518 | 1.32M | -0.1% | -$11.1K |
| D | 2024-03-27 | 2024-03-25 | ARDX | Kelliher Mike | See Remarks | A - Grant | $0.00 | +160.0K | 160.0K | New | $0 |
| 2024-03-22 | 2024-03-15 | ARDX | Blanks Robert | See Remarks | G - Gift | $0.00 | -1,000 | 367.2K | -0.3% | $0 | |
| T | 2024-03-22 | 2024-03-20 | ARDX | GRAMMER ELIZABETH A | See Remarks | S - Sale | $7.73 | -86.0K | 313.0K | -22% | -$664.8K |
| I | 2024-02-28 | 2024-02-26 | ARDX | Rosenbaum David P. | Chief Development Off | S - Sale | $9.20 | -5,183 | 175.9K | -3% | -$47.7K |
| 2024-02-22 | 2024-02-20 | ARDX | Rosenbaum David P. | Chief Development Off | S - Sale | $8.75 | -5,017 | 379.0K | -1% | -$43.9K | |
| I | 2024-02-22 | 2024-02-20 | ARDX | Rosenbaum David P. | Chief Development Off | S - Sale | $8.75 | -2,294 | 181.1K | -1% | -$20.1K |
| 2024-02-22 | 2024-02-20 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | S - Sale | $8.75 | -22.9K | 1.32M | -2% | -$200.5K | |
| 2024-02-22 | 2024-02-20 | ARDX | Rodriguez Susan | Chief Commercial Off | S - Sale | $8.75 | -6,928 | 452.8K | -2% | -$60.6K | |
| 2024-02-22 | 2024-02-20 | ARDX | Williams Laura A | Chief Medical Off | S - Sale | $8.75 | -4,803 | 380.1K | -1% | -$42.0K | |
| 2024-02-22 | 2024-02-20 | ARDX | GRAMMER ELIZABETH A | See Remarks | S - Sale | $8.75 | -4,432 | 399.0K | -1% | -$38.8K | |
| 2024-02-22 | 2024-02-20 | ARDX | Felsch Robert Ora | See Remarks | S - Sale | $8.75 | -2,352 | 184.8K | -1% | -$20.6K | |
| 2024-02-22 | 2024-02-20 | ARDX | Blanks Robert | See Remarks | S - Sale | $8.75 | -5,017 | 368.2K | -1% | -$43.9K | |
| 2024-02-22 | 2024-02-20 | ARDX | Renz Justin A | CFO | S - Sale | $8.75 | -5,341 | 304.8K | -2% | -$46.7K | |
| T | 2024-02-09 | 2024-02-08 | ARDX | Rosenbaum David P. | Chief Development Off | S - Sale | $9.18 | -15.3K | 384.0K | -4% | -$140.9K |
Purchase Sale Sale after option exercise All abbreviations